Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Atai Life Sciences N.V. (NQ: ATAI )

11.11 USD UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Dec 2, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 11.11
Bid (Size) 11.00 (1)
Ask (Size) 12.04 (1)
Prev. Close 11.11
Today's Range 11.11 - 11.11
52wk Range 10.45 - 22.91
Shares Outstanding N/A
Dividend Yield 54.02%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Use of Ketamine for Mental Disorders Rising While New Therapies Emerge
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Increasing Prevalence of Depression & Mental Health Disorders Fueling Huge Growth in Psychedelic Drugs Market
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert

Performance

YTD
-42.89%
-42.89%
1 Month
-34.66%
-34.66%
3 Month
-35.61%
-35.61%
6 Month
-42.89%
-42.89%
1 Year
-42.89%
-42.89%

More News

Read More
Ketamine’s Potential As A Treatment For Depression Has Drawn Major Industry Attention
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Analyst Ratings For ATAI Life Sciences
Tags Benzinga ATAI BZI/AAR
From Benzinga
Peter Thiel-Backed Psychedelic Start-Up, ATAI Life Sciences, Increases Stake In Compass Pathways
Tags Peter Thiel CMPS Government
From Benzinga
NetworkNewsAudio – Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) Offers Hope on the Smoking-Cessation Horizon
From InvestorBrandNetwork
Both Marijuana & Psychedelic Compounds-Based Drug Stocks Indexes Declined Sharply In November
Tags Stocks / Equities Market News Consumer Goods
From TalkMarkets
Breaking the Habit: Psychedelic Stigma Fades as Research Points to Critical Use in Smoking Cessation and More
From InvestorBrandNetwork
Analyst Ratings For ATAI Life Sciences
Tags Analyst Ratings Market News BZI/AAR
From Benzinga
Psychedelic Drug Stocks Continued To Decline Last Week
Tags Pharma/Biotech Market News Stocks / Equities
From TalkMarkets
Psychedelic Drug Stocks Have Plunged -10.6%, On Average, So Far In November
Tags Pharma/Biotech Stocks / Equities Market News
From TalkMarkets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.